Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational study

  1. Manzano, J.L.
  2. Martin-Liberal, J.
  3. Fernández-Morales, L.A.
  4. Benítez, G.
  5. Medina Martínez, J.
  6. Quindós, M.
  7. García-Castaño, A.
  8. Fernández, O.
  9. Simo, R.V.
  10. Majem, M.
  11. Bellido, L.
  12. Ayala de Miguel, P.
  13. Campos, B.
  14. Espinosa, E.
  15. Macías Cerrolaza, J.A.
  16. Gil-Arnaiz, I.
  17. Lorente, D.
  18. Rodriguez-Lescure, A.
  19. Perez, V.N.
  20. López Castro, R.
  21. Gramaje, M.G.
  22. Puértolas, T.
  23. Rodriguez Moreno, J.F.
  24. Espasa Font, L.
  25. Belaustegui Ferrández, G.
  26. Cerezuela-Fuentes, P.
  27. Show all authors +
Journal:
Melanoma research

ISSN: 1473-5636

Year of publication: 2023

Volume: 33

Issue: 5

Pages: 388-397

Type: Article

DOI: 10.1097/CMR.0000000000000888 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus